Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence

- Farrell, Michael, Shahbazi, Jeyran, Byrne, Marianne, Grebely, Jason, Lintzeris, Nicholas, Chambers, Mark, Larance, Briony, Ali, Robert, Nielsen, Suzanne, Dunlop, Adrian, Dore, Gregory J., McDonough, Michael, Montebello, Mark, Nicholas, Thomas, Weiss, Rob, Rodgers, Craig, Cook, Jon, Degenhardt, Louisa

Buprenorphine not detected on urine drug screening in supervised treatment

- Jamshidi, Nazila, Athavale, Akshay, Murnion, Bridin

Tracing the affordances of long-acting injectable depot buprenorphine: A qualitative study of patients’ experiences in Australia

- Barnett, Anthony, Savic, Michael, Lintzeris, Nicholas, Bathish, Ramez, Arunogiri, Shalini, Dunlop, Adrian J., Haber, Paul, Graham, Robert, Hayes, Vicky, Lubman, Dan I.

Acute experimental pain responses in methadone- and buprenorphine/naloxone-maintained patients administered additional opioid or gabapentin: a double-blind crossover pilot study

- Murnion, Bridin Patricia, Rivas, Consuelo, Demirkol, Apo, Hayes, Vicky, Lintzeris, Nicholas, Nielsen, Suzanne

Long-term safety of a weekly and monthly subcutaneous buprenorphine depot (CAM2038) in the treatment of adult out-patients with opioid use disorder

- Frost, Michael, Bailey, Genie L., Oosman, Sonia, Kim, Sonnie, Tiberg, Fredrik, Lintzeris, Nicholas, Strang, John, Dunlop, Adrian, Nunes, Edward V., Jansen, Jakob Billeskov, Frey, Lars Chemnitz, Weber, Bernd, Haber, Pauk

Understanding an emerging treatment population: Protocol for and baseline characteristics of a prospective cohort of people receiving treatment for pharmaceutical opioid dependence

- Nielsen, Suzanne, Lintzeris, Nicholas, Dunlop, Adrian, Demirkol, Apo, Silsbury, Catherine, Phung, Nghi, Houseman, Jennie, Larance, Briony, Murnion, Bridin, Degenhardt, Louisa, Bruno, Raimondo, Haber, Paul, Johnson, Jennifer, Hardy, Mark, Ling, Stephen, Saddler, Craig

Effectiveness and cost-effectiveness of unsupervised buprenorphine-naloxone for the treatment of heroin dependence in a randomized waitlist controlled trial

- Dunlop, Adrian J., Dunlop, AJ, Brown, AL, Oldmeadow, C, Attia, J, Harris, A, Ghijben, P, Sadler, C, Bell, J, Lintzeris, N, Brown, Amanda L., Hinman, Jennifer, Jackson, Melissa, Bell, James, Lintzeris, Nicholas, Oldmeadow, Christopher, Harris, Anthony, Gill, Anthony, Sadler, Craig, Ribbons, Karen, Attia, John, Barker, Daniel, Ghijben, Peter

QT interval prolongation in opioid agonist treatment: analysis of continuous 12-lead electrocardiogram recordings

- Isbister, Geoffrey K., Brown, Amanda L., Gill, Anthony, Scott, Alexander J., Calver, Leonie, Dunlop, Adrian J.

High-dose methadone transfer to buprenorphine in outpatient settings

- Naumovski, Branko, Batey, Robert G.

Correlates of pain in an in-treatment sample of opioid-dependent people

- Nielsen, Suzanne, Larance, Briony, Lintzeris, Nicholas, Black, Emma, Bruno, Raimondo, Murnion, Bridin, Dunlop, Adrian, Degenhardt, Louisa

Hypogonadism in men receiving methadone and buprenorphine maintenance treatment

- Hallinan, R., Byrne, A., Agho, K., McMahon, C. G., Tynan, P., Attia, J.

Erectile dysfunction in men receiving methadone and buprenorphine maintenance treatment

- Hallinan, Richard, Byrne, Andrew, Agho, Kingsley, McMahon, Chris, Tynan, Philip, Attia, John

Patient-centredness and opioid substitution

- Dunlop, Adrian